Genetic analysis and emergence of canine parvovirus type 2c in South Eastern Nigeria

Document Type: Short paper

Authors

1 Department of Veterinary Medicine, College of Veterinary Medicine, Michael Okpara University of Agriculture, Umudike, Nigeria

2 Research Directorate, National Veterinary Research Institute, Vom, Nigeria

3 Biotechnology Division, National Veterinary Research Institute, Vom, Nigeria

4 Department of Veterinary Medicine, Faculty of Veterinary Medicine, University of Nigeria, Nsukka, Nigeria

5 Department of Veterinary Parasitology and Entomology, Faculty of Veterinary Medicine, University of Nigeria, Nsukka, Nigeria

10.22099/ijvr.2020.31099.4693

Abstract

Background: Genetic analysis of canine parvovirus type 2 (CPV-2) variants circulating in South Eastern Nigeria was investigated. The original strain of CPV-2 emerged in 1978, mutated later to CPV-2a and has continued to be evolved. Aims: To genetically characterize CPV-2 strains detected in dogs in South Eastern Nigeria and to phylogenetically group the viruses with existing sequencing data. Methods: A total number of 82 rectal swabs were collected and stored in virus transport medium (VTM) from suspected cases of CPV-2 within the study area and were tested with polymerase chain reaction (PCR). Results: Seventy-nine samples (96.3%) were positive for CPV-2 and sequence analysis of partial VP2 gene of 20 amplicons revealed circulation of CPV-2a (n=4) and CPV-2c (n=16) in the region. The obtained strains clustered together. However, the group was further divided into two clear clusters comprising of 2a and 2c strains. The vaccine strain and the CPV-2 reference strains from USA formed a monophyletic cluster. Conclusion: Canine parvovirus types 2a and 2c are co-circulating in South Eastern region of Nigeria and therefore, there is an urgent need for an improved vaccine to cover for the emerging strain (CPV-2c) in Nigeria.

Keywords


Apaa, TT; Daly, JM and Tarlinton, RE (2016). Canine parvovirus (CPV-2) variants circulating in Nigerian dogs. Vet. Rec., 3: 1-5.

Buonavoglia, C; Martella, V; Pratelli, A; Tempesta, M; Cavalli, A; Buonavoglia, D; Bozzo, G; Ella, G; Decaro, N and Carmichael, L (2001). Evidence for evolution of canine parvovirus type 2 in Italy. J. Gen Virol., 82: 3021-3025.

Chalmers, WSK; Truyen, U; Greenwood, NM and Baxendale, W (1999). Efficacy of feline panleukopenia vaccine prevent infection with an isolate of CPV-2b obtained from cat. Vet. Microbiol., 690: 41-45.

Chiang, S; Wu, H; Chiou, M; Chang, M and Lin, C (2016). Identification of a novel canine parvovirus type 2c in Taiwan. Virol. J., 13: 1-7.

Decaro, N; Cirone, F; Desario, C; Elia, G; Lorusso, E; Colaianni, ML; Martella, V and Buonavoglia, C (2009a). Severe parvovirus in a 12-year old dog that had been repeatedly vaccinated. Vet. Rec., 164: 593-595.

Decaro, N; Desario, C; Addie, DD; Martella, V; Vieira, MJ; Elia, G; Zicola, A; Davis, C; Thompson, G; Thiry, E; Truyen, U and Buonavoglia, C (2007). Molecular epidemiology of canine parvovirus, Europe. Emerg. Infect. Dis., 13: 1222-1224.

Decaro, N; Desario, C; Elia, G; Martella, V; Mari, V; Lavazza, A; Nardi, M and Buonavoglia, C (2008). Evidence for immunisation failure in vaccinated adult dogs infected with canine parvovirus type 2c. New Microbiol., 31: 125-130.

Decaro, N; Desario, C; Parisi, A; Martella, V; Lorusso, A; Miccolupo, A; Mari, V; Colaianni, ML; Cavalli, A; Di Trani, L and Buonavoglia, C (2009b). Genetic analysis of canine parvovirus type 2c. Virology. 385: 5-10.

Dogonyaro, BB; Bosman, AM; Sibeko, KP; Venter, EH and van Vuuren, M (2013). Genetic analysis of the VP2-encoding gene of canine parvovirus strains from Africa. Vet. Microbiol., 165: 460-465.

Fagbohun, AO and Omobowale TO (2018). Sequence and phylogenetic analysis of canine parvovirus-2 isolates in dogs revealed circulation of three subtypes in Nigeria. Virus Dis., 3: 411-415.

Goddard, A and Leisewitz, AL (2010). Canine parvovirus. Vet. Clin. Small Anim. Pract., 40: 1041-1053.

Larson, LJ and Schultz, RD (2008). Do two current canine parvovirus type 2 and 2b vaccines provide protection against the new type 2c variant? Vet. Ther.? 9: 94-101.

Li, G; Ji, S; Zhai, X; Zhang, Y; Liu, J; Zhu, M; Zhou, J and Su, S (2017). Evolutionary and genetic analysis of the VP2 gene of canine parvovirus. BMC Genomics. 18: 1-13.

Martella, V; Decaro, N and Buonavoglia, C (2006). Evolution of CPV-2 and implication for antigenic/genetic characterization. Virus Genes. 33: 11-13.

Muzyczka, N and Berns, KI (2001). Parvoviridae: the viruses and their replication. In: Knipe, DM and Howley, PM (Eds.), Fields virology. (4th Edn.), Philadephia, PA, Lippincott Williams & Wilkins. PP: 2327-2359.

Nakamura, M; Tohya, Y; Miyazawa, T; Mochizuki, M; Phung, HT and Nguyen, NH (2004). A novel antigenic variant of canine parvovirus from a Vietnamese dog. Arch. Virol., 149: 2261-2269.

Parrish, CR; Aquadro, CF and Carmichael, LE (1998). Canine host range and a specific epitope map along with variant sequences in the capsid protein gene of canine parvovirus and related feline, mink and racoon parvoviruses. Virology. 166: 293-307.

Pollock, RVH and Coyne, MJ (1993). Canine parvovirus. Vet. Clin. North Am., 23: 555-568.

Spibey, N; Greenwood, NM; Sutton, D; Chalmers, WS and Tarpey, I (2008). Canine parvovirus type 2 vaccine protects against virulent challenge with type 2c virus. Vet. Microbiol., 128: 48-55.

Steinel, A; Parrish, CR; Bloom, ME and Truyen, U (2001). Parvovirus infections in wild carnivores. J. Wild. Dis., 37: 594-607.

Sykes, JE (2014). Canine parvovirus infections and other viral enteritides. In: Sykes, JE (Ed.), Canine and feline infectious diseases. (1st Edn.), St Louis, MO: Elsevier. 2014: 141-151.

Tattersall, P; Bergoin, M; Bloom, ME; Brown, KE; Linden, RM; Muzyczka, N; Parrish, CR and Tijssen, P (2005). Family Parvoviridae. In: Fauquet, CM; Mayo, MA; Maniloff, J; Desselberger, U and Ball, LA (Eds.), Virus Taxonomy: 8th Report of the International Committee on Taxonomy of Viruses. San Dieogo, Elsevier Academic Press. PP: 353-369.

Timurkan, MO and Oguzoglu, TC (2015). Molecular characterization of canine parvovirus (CPV) infection in dogs in Turkey. Vet. Ital., 51: 39-44.

Touihri, L; Bouzid, I; Daoud, R; Desario, CE; Goulli, AF; Decaro, N and Bahloul, C (2009). Molecular characterization of canine parvovirus-2 variants circulating in Tunisia. Virus Genes. 38: 249-258.

Truyen, U (2006). Evolution of canine parvovirus: a need for new vaccines? Vet. Microbiol., 117: 9-13.

Yule, TD; Roth, MB; Dreier, K; Johnson, AF; Palmer-Densmore, M; Simmons, K and Fanton, R (1997). Canine parvovirus vaccine elicits protection from the inflammatory and clinical consequences of the disease. Vaccine. 15: 720-729.